Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

OBJECT: Gliadel (BCNU) wafer and concomitant temozolomide (TMZ) therapy, when used individually as adjuvant therapies, extend survival from that achieved by resection and radiation therapy (XRT) for glioblastoma multiforme (GBM). It remains unstudied whether combining Gliadel and TMZ therapy is safe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurosurg
Egile Nagusiak: McGirt, Matthew J., Than, Khoi D., Weingart, Jon D., Chaichana, Kaisorn L., Attenello, Frank J., Olivi, Alessandro, Laterra, John, Kleinberg, Lawrence R., Grossman, Stuart A., Brem, Henry, Quiñones-Hinojosa, Alfredo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856017/
https://ncbi.nlm.nih.gov/pubmed/19046047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2008.5.17557
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak